A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future by Douglas Galasko, Philip Scheltens

Get full text

Heterogeneity of Alzheimer’s disease: consequence for drug trials? by Gayatri Devi, Philip Scheltens

Get full text

Cognitive Decline in Patients with Chronic Hydrocephalus and Normal Aging: ‘Growing into Deficits' by Marlijn H. de Beer, Philip Scheltens

Get full text

Does MRI Increase the Diagnostic Confidence of Physicians in an Outpatient Memory Clinic by Leo Boelaarts, Philip Scheltens, Jos de Jonghe

Get full text

The “rights” of precision drug development for Alzheimer’s disease by Jeffrey Cummings, Howard H. Feldman, Philip Scheltens

Get full text

White Matter Changes: New Perspectives on Imaging, Clinical Aspects, and Intervention by Sofia Madureira, Ana Verdelho, Leonardo Pantoni, Philip Scheltens

Get full text

The predictive value of normal EEGs in dementia due to Alzheimer’s disease by Casper T. Briels, Cornelis J. Stam, Philip Scheltens, Alida A. Gouw

Get full text

Virtual neural network-guided optimization of non-invasive brain stimulation in Alzheimer's disease. by Janne J Luppi, Cornelis J Stam, Philip Scheltens, Willem de Haan

Get full text

Clinical symptoms and risk factors in cerebral microangiopathy patients. by Sandra Okroglic, Catherine N Widmann, Horst Urbach, Philip Scheltens, Michael T Heneka

Get full text

Testing Episodic Memory in Elderly Subjects: Not as Simple as It Looks by Leo Boelaarts, Sascha R.A. Meyer, Philip Scheltens, Jos F.M. de Jonghe

Get full text

Can agrin cerebrospinal fluid concentration be used as an early biomarker for Alzheimer's disease? by Marta Del Campo Milan, Leah Zuroff, Connie R. Jimenez, Philip Scheltens, Charlotte E. Teunissen

Get full text

Vroegdiagnostiek van de ziekte van Alzheimer: de rol van Positron Emissie Tomografie (PET) by Wiesje M. van der Flier, Rik Ossenkoppele, Bart N. M. van Berckel, Philip Scheltens

Get full text

Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias by Claudia Cicognola, Oskar Hansson, Philip Scheltens, Hlin Kvartsberg, Henrik Zetterberg, Charlotte E. Teunissen, Kaj Blennow

Get full text

Activity dependent degeneration explains hub vulnerability in Alzheimer's disease. by Willem de Haan, Katherine Mott, Elisabeth C W van Straaten, Philip Scheltens, Cornelis J Stam

Get full text

Sensitive and reproducible MEG resting-state metrics of functional connectivity in Alzheimer’s disease by Deborah N. Schoonhoven, Casper T. Briels, Arjan Hillebrand, Philip Scheltens, Cornelis J. Stam, Alida A. Gouw

Get full text

Reproducibility of EEG functional connectivity in Alzheimer’s disease by Casper T. Briels, Deborah N. Schoonhoven, Cornelis J. Stam, Hanneke de Waal, Philip Scheltens, Alida A. Gouw

Get full text

Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies by Inger van Steenoven, Wiesje M. van der Flier, Philip Scheltens, Charlotte E. Teunissen, Afina W. Lemstra

Get full text

Clinical Features of Patients with Alzheimer’s Disease and a History of Traumatic Brain Injury by Suzan van Amerongen, Dewi K. Caton, Yolande A.L. Pijnenburg, Philip Scheltens, Everard G.B. Vijverberg

Get full text

Routine magnetoencephalography in memory clinic patients: A machine learning approach by Alida A. Gouw, Arjan Hillebrand, Deborah N. Schoonhoven, Matteo Demuru, Peterjan Ris, Philip Scheltens, Cornelis J. Stam

Get full text

Exercise and Early-Onset Alzheimer’s Disease: Theoretical Considerations by Astrid M. Hooghiemstra, Laura H.P. Eggermont, Philip Scheltens, Wiesje M. van der Flier, Erik J.A. Scherder

Get full text